DAYVIGO is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Eisai Inc.. The primary component is Lemborexant.
| Product ID | 62856-405_08ce5d4f-11e3-42c9-9e5a-801a3afca000 |
| NDC | 62856-405 |
| Product Type | Human Prescription Drug |
| Proprietary Name | DAYVIGO |
| Generic Name | Lemborexant |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2020-04-07 |
| Marketing Category | NDA / NDA |
| Application Number | NDA212028 |
| Labeler Name | Eisai Inc. |
| Substance Name | LEMBOREXANT |
| Active Ingredient Strength | 5 mg/1 |
| DEA Schedule | CIV |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2020-04-07 |
| NDC Exclude Flag | N |
| Sample Package? | Y |
| Marketing Category | NDA |
| Application Number | NDA212028 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2020-04-07 |
| Marketing Category | NDA |
| Application Number | NDA212028 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-04-07 |
| Marketing Category | NDA |
| Application Number | NDA212028 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2020-04-07 |
| Ingredient | Strength |
|---|---|
| LEMBOREXANT | 5 mg/1 |
| SPL SET ID: | 7074cb65-77b3-45d2-8e8d-da8dc0f70bfd |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 62856-405 | DAYVIGO | lemborexant |
| 62856-410 | DAYVIGO | lemborexant |
| 62856-455 | DAYVIGO | lemborexant |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() DAYVIGO 88655847 not registered Live/Pending |
Eisai R&D Management Co., Ltd. 2019-10-15 |
![]() DAYVIGO 88058574 not registered Live/Pending |
Eisai R&D Management Co., Ltd. 2018-07-30 |